Harrow Health, Inc. (HROW) - Form 8-K Summary
Business Context and Reporting Period
This Current Report on Form 8-K was filed by Harrow Health, Inc. on January 10, 2022. The registrant is incorporated in Delaware and operates with principal executive offices in Nashville, Tennessee. The company's common stock and 8.625% Senior Notes due April 2026 are traded on The NASDAQ Global Market under the symbols HROW and HROWL, respectively.
Financial Metrics
This filing does not contain specific financial performance data such as revenue, profit, cash flow, margins, debt levels, or liquidity metrics. The document serves as a disclosure of materials rather than a financial results report.
Material Changes
No material changes to financial condition or operations are reported in this filing. The report focuses on the distribution of investor presentation materials.
Guidance, Outlook, and Disclosures
Item 7.01 discloses the attachment of a corporate presentation (Exhibit 99.1) and an information sheet (Exhibit 99.2) dated January 2022. These materials are intended for use by management at investor conferences and meetings. The filing explicitly states that the information contained in these exhibits is not deemed "filed" for purposes of Section 18 of the Exchange Act and is not incorporated by reference into other filings unless expressly referenced.
Key Facts for Investor Verification
- Verify the content of the attached Exhibits 99.1 and 99.2 for any forward-looking statements or strategic updates, as the 8-K itself contains no numerical data.
- Confirm the trading status of the 8.625% Senior Notes due April 2026 (HROWL) on the NASDAQ Global Market.
- Note that the presentation materials are not legally "filed" and carry different liability standards than formal SEC financial reports.
- Review the company's official investor relations website for the full text of the January 2022 presentation referenced in this filing.